SILVERCREST ASSET MANAGEMENT GROUP LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 204 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 16.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
SILVERCREST ASSET MANAGEMENT GROUP LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,828,484
-39.2%
83,246
-24.1%
0.03%
-35.6%
Q2 2023$6,301,413
+8.5%
109,647
-29.2%
0.04%
+2.3%
Q1 2023$5,807,550
-7.1%
154,868
-30.6%
0.04%
-8.3%
Q4 2022$6,252,887
-1.2%
223,158
-0.9%
0.05%
-7.7%
Q3 2022$6,327,000
-21.4%
225,156
-2.6%
0.05%
-14.8%
Q2 2022$8,046,000
-7.3%
231,276
-4.3%
0.06%
+8.9%
Q1 2022$8,677,000
+1.0%
241,701
-34.5%
0.06%
+3.7%
Q4 2021$8,593,000
+22.5%
368,9510.0%0.05%
+14.9%
Q3 2021$7,014,000
-7.8%
368,951
-2.3%
0.05%
-6.0%
Q2 2021$7,609,000
+41.5%
377,455
+28.6%
0.05%
+38.9%
Q1 2021$5,378,000
-19.6%
293,582
-11.8%
0.04%
-26.5%
Q4 2020$6,693,000
+27.1%
332,797
+18.4%
0.05%
+8.9%
Q3 2020$5,268,000
-18.1%
280,980
-1.9%
0.04%
-21.1%
Q2 2020$6,431,000
+48.7%
286,320
-1.7%
0.06%
+23.9%
Q1 2020$4,324,000
-25.3%
291,352
-3.0%
0.05%
+2.2%
Q4 2019$5,792,000
+26.4%
300,270
+30.0%
0.04%
+18.4%
Q3 2019$4,582,000231,0410.04%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders